← Leaderboards
Erle S Robertson
University Of Michigan At Ann Arbor
$33,256,575
Attributed
$33,256,575
Total exposure
26
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$54,094,261 · 29
By mechanism
P01$23,126,745 · 9
R01$19,459,940 · 12
T32$5,614,065 · 2
U54$4,870,770 · 3
P30$976,991 · 2
R29$45,750 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralMalignant NeoplasmsHuman Herpesvirus 8VirusCellsB-LymphocytesProgramsTumorigenesisLinkGenesGenomeMediatingGammaherpesvirusRegulationInsightLymphomaProteinsInfectionAntigensResearch PersonnelTumorComplexAcquired Immunodeficiency SyndromeKaposi Sarcoma
Grant awards (140)
Transcription and Replication of Oncogenic Viruses in Hypoxia$2,596,866
P01 · FY2025 · CA · contact PI
Tumor suppressor reprogramming by EBV through post-translational modification$1,457,079
R01 · FY2025 · CA · contact PI
Project 1: KSHV reprograms replication and metabolic activities in hypoxia$468,526
P01 · FY2025 · CA · contact PI
Training in Tumor Virology$461,022
T32 · FY2025 · CA · contact PI
Next Generation Sequencing Core$421,604
P01 · FY2025 · CA · contact PI
Virus, Vector and Cell Culture Core$280,416
P01 · FY2025 · CA · contact PI
Administrative Core$109,250
P01 · FY2025 · CA · contact PI
Transcription and Replication of Oncogenic Viruses in Hypoxia$2,608,181
P01 · FY2024 · CA · contact PI
Project 1: KSHV reprograms replication and metabolic activities in hypoxia$468,525
P01 · FY2024 · CA · contact PI
Training in Tumor Virology$453,518
T32 · FY2024 · CA · contact PI
Next Generation Sequencing Core$424,496
P01 · FY2024 · CA · contact PI
Virus, Vector and Cell Culture Core$280,416
P01 · FY2024 · CA · contact PI
Tumor suppressor reprogramming by EBV through post-translational modification$110,346
R01 · FY2024 · CA · contact PI
Administrative Core$109,250
P01 · FY2024 · CA · contact PI
Transcription and Replication of Oncogenic Viruses in Hypoxia$2,696,989
P01 · FY2023 · CA · contact PI
Tumor suppressor reprogramming by EBV through post-translational modification$533,268
R01 · FY2023 · CA · contact PI
Epigenetic Regulation of KSHV Genome Replication$501,823
R01 · FY2023 · CA · contact PI
Project 1: KSHV reprograms replication and metabolic activities in hypoxia$468,525
P01 · FY2023 · CA · contact PI
Next Generation Sequencing Core$456,703
P01 · FY2023 · CA · contact PI
Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia$455,512
P01 · FY2023 · CA · contact PI
Virus, Vector and Cell Culture Core$309,467
P01 · FY2023 · CA · contact PI
Botswana-UPenn: Research Consortium of HPV-Related Cervical Cancer in HIV Patient$133,907
U54 · FY2023 · CA · contact PI
Administrative Core$113,297
P01 · FY2023 · CA · contact PI
Botswana-UPenn: Research Consortium of HPV-Related Cervical Cancer in HIV Patient$69,300
U54 · FY2023 · CA · contact PI
Tumor suppressor reprogramming by EBV through post-translational modification$539,377
R01 · FY2022 · CA · contact PI
Epigenetic Regulation of KSHV Genome Replication$501,823
R01 · FY2022 · CA · contact PI
Epigenetic Regulation of KSHV Genome Replication$501,823
R01 · FY2021 · CA · contact PI
Training in Tumor Virology$341,268
T32 · FY2021 · CA · contact PI
Epigenetic Regulation of KSHV Genome Replication$495,670
R01 · FY2020 · CA · contact PI
Training in Tumor Virology$342,047
T32 · FY2020 · CA · contact PI
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients$952,873
U54 · FY2019 · CA · contact PI
Natural History & Pathogenesis of HPV in HIV infected women with cervical cancer$533,574
U54 · FY2019 · CA · contact PI
Epigenetic Regulation of KSHV Genome Replication$498,100
R01 · FY2019 · CA · contact PI
Training in Tumor Virology$337,544
T32 · FY2019 · CA · contact PI
Tumor Virology Research Program$7,211
P30 · FY2019 · CA · contact PI
Tumor Virology Research Program$5,768
P30 · FY2019 · CA · contact PI
Tumor Virology Research Program$3,626
P30 · FY2019 · CA · contact PI
Tumor Virology Research Program$1,106
P30 · FY2019 · CA · contact PI
Early Events in KSVH Infection of Primary B-cells$1,110,758
P01 · FY2018 · CA · contact PI
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients$717,526
U54 · FY2018 · CA · contact PI
Training in Tumor Virology$319,088
T32 · FY2018 · CA · contact PI
Tumor Virology Research Program$155,631
P30 · FY2018 · CA · contact PI
Tumor Virology Research Program$9,404
P30 · FY2018 · CA · contact PI
Tumor Virology Research Program$2,510
P30 · FY2018 · CA · contact PI
Tumor Virology Research Program$2,143
P30 · FY2018 · CA · contact PI
Early Events in KSVH Infection of Primary B-cells$1,571,505
P01 · FY2017 · CA · contact PI
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients$723,588
U54 · FY2017 · CA · contact PI
Training in Tumor Virology$369,654
T32 · FY2017 · CA · contact PI
Role of LANA-RBP-jk During Early KSHV Infection$341,337
P01 · FY2017 · CA · contact PI
Genome Persistence of KSHV$298,800
R01 · FY2017 · CA · contact PI
Administrative Core$115,227
P01 · FY2017 · CA · contact PI
Tumor Virology Research Program$73,099
P30 · FY2017 · CA · contact PI
Training In Tumor Virology$3,684
T32 · FY2017 · CA · contact PI
Early Events in KSVH Infection of Primary B-cells$1,746,424
P01 · FY2016 · CA · contact PI
Role of LANA-RBP-jk During Early KSHV Infection$379,491
P01 · FY2016 · CA · contact PI
Genome Persistence of KSHV$298,800
R01 · FY2016 · CA · contact PI
CELL CULTURE CORE$131,262
P30 · FY2016 · DK · contact PI
Administrative Core$128,111
P01 · FY2016 · CA · contact PI
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients$86,741
U54 · FY2016 · CA · contact PI
Tumor Virology Research Program$72,887
P30 · FY2016 · CA · contact PI
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients$50,000
U54 · FY2016 · CA · contact PI
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients$747,798
U54 · FY2015 · CA · contact PI
Early Events in KSVH Infection of Primary B-cells$642,109
P01 · FY2015 · CA · contact PI
Training In Tumor Virology$342,954
T32 · FY2015 · CA · contact PI
Genome Persistence of KSHV$298,800
R01 · FY2015 · CA · contact PI
KSHV genome modification in KS tissue$200,000
R01 · FY2015 · CA · contact PI
Role of LANA-RBP-jk During Early KSHV Infection$134,054
P01 · FY2015 · CA · contact PI
CELL CULTURE CORE$131,262
P30 · FY2015 · DK · contact PI
Administrative Core$45,255
P01 · FY2015 · CA · contact PI
Early Events in KSVH Infection of Primary B-cells$1,771,294
P01 · FY2014 · CA · contact PI
Botswana-UPENN Research Consortium of HPV-related Cervical Cancer in HIV Patients$750,000
U54 · FY2014 · CA · contact PI
Role of LANA-RBP-jk During Early KSHV Infection$374,854
P01 · FY2014 · CA · contact PI
Training In Tumor Virology$337,821
T32 · FY2014 · CA · contact PI
Genome Persistence of KSHV$289,837
R01 · FY2014 · CA · contact PI
KSHV genome modification in KS tissue$194,000
R01 · FY2014 · CA · contact PI
CELL CULTURE CORE$131,262
P30 · FY2014 · DK · contact PI
Administrative Core$120,498
P01 · FY2014 · CA · contact PI
Natural History & Pathogenesis of HPV in HIV infected women with cervical cancer$105,463
U54 · FY2014 · CA · contact PI
Early Events in KSVH Infection of Primary B-cells$1,861,827
P01 · FY2013 · CA · contact PI
Role of LANA-RBP-jk During Early KSHV Infection$385,753
P01 · FY2013 · CA · contact PI
Training In Tumor Virology$321,407
T32 · FY2013 · CA · contact PI
Genome Persistence of KSHV$298,800
R01 · FY2013 · CA · contact PI
EBV Antigen and Cell Cycle Regulation$268,189
R01 · FY2013 · CA · contact PI
KSHV genome modification in KS tissue$200,000
R01 · FY2013 · CA · contact PI
Administrative Core$130,225
P01 · FY2013 · CA · contact PI
CELL CULTURE CORE$118,558
P30 · FY2013 · DK · contact PI
Training In Tumor Virology$321,587
T32 · FY2012 · CA · contact PI
EBV Antigen and Cell Cycle Regulation$285,308
R01 · FY2012 · CA · contact PI
CELL CULTURE CORE$131,262
P30 · FY2012 · DK · contact PI
EBV Antigen and Cell Cycle Regulation$285,308
R01 · FY2011 · CA · contact PI
Training In Tumor Virology$283,732
T32 · FY2011 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$270,871
R01 · FY2011 · CA · contact PI
KSHV Latency control by Rta$334,185
R01 · FY2010 · AI · contact PI
EBNA3C and tumor supressors$319,550
R01 · FY2010 · CA · contact PI
EBV Antigen and Cell Cycle Regulation$294,131
R01 · FY2010 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$279,248
R01 · FY2010 · CA · contact PI
Training in Tumor Virology$269,835
T32 · FY2010 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$80,555
R01 · FY2010 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$468,248
R01 · FY2009 · CA · contact PI
KSHV Latency control by Rta$337,560
R01 · FY2009 · AI · contact PI
EBNA3C and tumor supressors$317,683
R01 · FY2009 · CA · contact PI
EBV Antigen and Cell Cycle Regulation$294,131
R01 · FY2009 · CA · contact PI
Training in Tumor Virology$273,119
T32 · FY2009 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$78,040
R01 · FY2009 · CA · contact PI
KSHV Latency control by Rta$337,560
R01 · FY2008 · AI · contact PI
Mechanism of EBNA mediated cell migration$332,863
R01 · FY2008 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$279,248
R01 · FY2008 · CA · contact PI
Training in Tumor Virology$229,654
T32 · FY2008 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$189,000
R01 · FY2008 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$75,288
R01 · FY2008 · CA · contact PI
Mechanism of EBNA mediated cell migration$333,017
R01 · FY2007 · CA · contact PI
Training in Tumor Virology$295,527
T32 · FY2007 · CA · contact PI
Mechanisms of Action of LANA encoded by KSHV$279,248
R01 · FY2007 · CA · contact PI
KSHV Latency control by Rta$267,632
R01 · FY2007 · AI · contact PI
Mechanism of KSHV reactivation$263,002
R01 · FY2007 · DE · contact PI
Mechanism of EBNA mediated cell migration$343,117
R01 · FY2006 · CA · contact PI
Training in Tumor Virology$310,604
T32 · FY2006 · CA · contact PI
KSHV Latency control by Rta$274,750
R01 · FY2006 · AI · contact PI
Mechanism of KSHV reactivation$270,857
R01 · FY2006 · DE · contact PI
Role of EBNA3C in B Lymphocyte Transformation$270,522
R01 · FY2006 · CA · contact PI
Mechanism of Action LANA Encoded by KSHV$265,833
R01 · FY2006 · CA · contact PI
Mechanism of EBNA mediated cell migration$351,527
R01 · FY2005 · CA
EBV Associated Head and Neck Cancers$279,891
R01 · FY2005 · DE
Mechanism of KSHV reactivation$277,375
R01 · FY2005 · DE
Role of EBNA3C in B Lymphocyte Transformation$277,032
R01 · FY2005 · CA
Mechanism of Action LANA Encoded by KSHV$272,231
R01 · FY2005 · CA
Mechanism of EBNA mediated cell migration$351,675
R01 · FY2004 · CA
EBV Associated Head and Neck Cancers$280,049
R01 · FY2004 · DE
Role of EBNA3C in B Lymphocyte Transformation$277,032
R01 · FY2004 · CA
Mechanism of Action LANA Encoded by KSHV$272,231
R01 · FY2004 · CA
EBV Associated Head and Neck Cancers$280,202
R01 · FY2003 · DE
Role of EBNA3C in B Lymphocyte Transformation$277,032
R01 · FY2003 · CA
Mechanism of Action LANA Encoded by KSHV$272,231
R01 · FY2003 · CA
Mechanism of Action LANA Encoded by KSHV$272,231
R01 · FY2002 · CA
Role of EBNA3C in B Lymphocyte Transformation$251,215
R01 · FY2002 · CA
EBV Associated Head and Neck Cancers$240,935
R01 · FY2002 · DE
EBV Associated Head and Neck Cancers$24,447
R01 · FY2002 · DE
Role of EBNA3C in B Lymphocyte Transformation$21,762
R01 · FY2002 · CA
EBV Associated Head and Neck Cancers$267,552
R01 · FY2001 · DE
EBNA3C AND B LYMPHOCYTE TRANSFORMATION$45,750
R29 · FY2000 · CA